These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38789351)

  • 21. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ; Cadiz ML; Natavio AM
    Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
    [No Abstract]   [Full Text] [Related]  

  • 22. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.
    Colon Hidalgo D; Patel J; Masic D; Park D; Rech MA
    J Crit Care; 2020 Feb; 55():145-148. PubMed ID: 31731173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimodal strategy to counteract vasodilation in septic shock.
    Leone M; Einav S; Antonucci E; Depret F; Lakbar I; Martin-Loeches I; Wieruszewski PM; Myatra SN; Khanna AK
    Anaesth Crit Care Pain Med; 2023 Jun; 42(3):101193. PubMed ID: 36621622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasopressor support in managing acute spinal cord injury: current knowledge.
    Yue JK; Tsolinas RE; Burke JF; Deng H; Upadhyayula PS; Robinson CK; Lee YM; Chan AK; Winkler EA; Dhall SS
    J Neurosurg Sci; 2019 Jun; 63(3):308-317. PubMed ID: 28252264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of parameters associated with hypotension requiring vasopressor support after carotid angioplasty and stenting.
    Trocciola SM; Chaer RA; Lin SC; Ryer EJ; De Rubertis B; Morrissey NJ; McKinsey J; Kent KC; Faries PL
    J Vasc Surg; 2006 Apr; 43(4):714-20. PubMed ID: 16616226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a personalized early start of norepinephrine in septic shock.
    Monnet X; Lai C; Ospina-Tascon G; De Backer D
    Crit Care; 2023 Aug; 27(1):322. PubMed ID: 37608327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiogenic shock: Inotropes and vasopressors.
    Amado J; Gago P; Santos W; Mimoso J; de Jesus I
    Rev Port Cardiol; 2016 Dec; 35(12):681-695. PubMed ID: 27836218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choosing a Vasopressor for a Prehospital Emergency Medical System: Consideration for Agent Selection and Review of Pharmacologic Profiles, Efficacy, and Safety in Treatment of Shock.
    Feldman R; Stanton M; Chinn M; Grawey T; Weston B
    WMJ; 2020 Dec; 119(4):240-247. PubMed ID: 33428833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasopressor use in cardiogenic shock.
    Levy B; Klein T; Kimmoun A
    Curr Opin Crit Care; 2020 Aug; 26(4):411-416. PubMed ID: 32487842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressors in Trauma: A Never Event?
    Richards JE; Harris T; Dünser MW; Bouzat P; Gauss T
    Anesth Analg; 2021 Jul; 133(1):68-79. PubMed ID: 33908898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasopressor Therapy in the Intensive Care Unit.
    Russell JA; Gordon AC; Williams MD; Boyd JH; Walley KR; Kissoon N
    Semin Respir Crit Care Med; 2021 Feb; 42(1):59-77. PubMed ID: 32820475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complications from Administration of Vasopressors Through Peripheral Venous Catheters: An Observational Study.
    Medlej K; Kazzi AA; El Hajj Chehade A; Saad Eldine M; Chami A; Bachir R; Zebian D; Abou Dagher G
    J Emerg Med; 2018 Jan; 54(1):47-53. PubMed ID: 29110979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK.
    Priyanka P; Chang CH; Chawla LS; Kellum JA; Clermont G; Murugan R
    Shock; 2022 Oct; 58(4):260-268. PubMed ID: 36018286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of the evidence supporting a role for vasopressor support in acute SCI.
    Ploumis A; Yadlapalli N; Fehlings MG; Kwon BK; Vaccaro AR
    Spinal Cord; 2010 May; 48(5):356-62. PubMed ID: 19935758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.
    Levy B; Clere-Jehl R; Legras A; Morichau-Beauchant T; Leone M; Frederique G; Quenot JP; Kimmoun A; Cariou A; Lassus J; Harjola VP; Meziani F; Louis G; Rossignol P; Duarte K; Girerd N; Mebazaa A; Vignon P;
    J Am Coll Cardiol; 2018 Jul; 72(2):173-182. PubMed ID: 29976291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Push-Dose Vasopressin for Hypotension in Septic Shock.
    Nowadly CD; Catlin JR; Fontenette RW
    J Emerg Med; 2020 Feb; 58(2):313-316. PubMed ID: 32173168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure.
    Møller MH; Claudius C; Junttila E; Haney M; Oscarsson-Tibblin A; Haavind A; Perner A
    Acta Anaesthesiol Scand; 2016 Nov; 60(10):1347-1366. PubMed ID: 27576362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of Refractory Vasodilatory Shock.
    Jentzer JC; Vallabhajosyula S; Khanna AK; Chawla LS; Busse LW; Kashani KB
    Chest; 2018 Aug; 154(2):416-426. PubMed ID: 29329694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The medical treatment of cardiogenic shock: cardiovascular drugs.
    De Backer D; Arias Ortiz J; Levy B
    Curr Opin Crit Care; 2021 Aug; 27(4):426-432. PubMed ID: 33797431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-Line Vasopressor Use in Septic Shock and Route of Administration: An Epidemiologic Study.
    Teja B; Bosch NA; Wijeysundera DN; Wijeysundera HC; Saskin R; Hill AD; Stelfox HT; Walkey AJ; Wunsch H
    Ann Am Thorac Soc; 2022 Oct; 19(10):1713-1721. PubMed ID: 35709214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.